Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMO... by Nakase, H., Motoya, S., Matsumoto, T., Watanabe, K., Hisamatsu, T., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Esaki, M., Nagahori, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T., Andoh, Akira, Ashida, Toshifumi, Endo, Katsuya, Endo, Yutaka, Esaki, Motohiro, Fujita, Hiroshi, Fujiya, Mikihiro, Haruma, Ken, Hibi, Toshifumi, Hiraoka, Sakiko, Hirata, Ichiro, Hisamatsu, Tadakazu, Honda, Yutaka, Iijima, Hideki, Iizuka, Bunei, Ikeya, Kentaro, Inoue, Takuya, Inoue, Shuji, Ishida, Tetsuya, Ishiguro, Yo, Ishihara, Shunji, Ito, Hiroaki, Iwakiri, Ryuichi, Kagaya, Takashi, Kanai, Takanori, Kashida, Hiroshi, Kato, Shingo, Kato, Jun, Katsurada, Takehiko, Kinjyo, Fukunori, Kobayashi, Kiyonori, Kodama, Mayumi, Kunisaki, Reiko, Kurahara, Koichi, Kurokami, Takafumi, Kyouwon, Lee, Matsuda, Koichiro, Matsueda, Kazuhiro, Matsui, Toshiyuki, Matsumoto, Takayuki, Mitsuyama, Keiichi, Mizokami, Yuji, Motoya, Satoshi, Naito, Yuji, Nakagawa, Tomoo, Nakamura, Shiro, Nakase, Hiroshi, Nojima, Masanori, Nomura, Masafumi, Ogawa, Atsuhiro, Okazaki, Kazuichi, Otsuka, Kazuaki, Sakuraba, Hirotake, Saruta, Masayuki, Sasaki, Makoto, Shirai, Takayuki, Suga, Tomoaki, Sugimura, Kazuhito, Sugiyama, Toshiro, Suzuki, Yasuo, Takeshima, Fuminao, Tamaki, Hiroyuki, Tanaka, Shinji, Tanida, Satoshi, Tominaga, Keiichi, Tomizawa, Taku, Watanabe, Kenji, Watanabe, Mamoru, Yamamoto, Shojiro, Yamashita, Masaki, Yoshida, Atsushi, Yoshimura, Naoki

Get full text

Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis by Okahara, S., Arimura, Y., Yabana, T., Kobayashi, K., Gotoh, A., Motoya, S., Imamura, A., Endo, T., Imai, K.

Get full text

P760 Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety data by Matsuoka, K, Motoya, S, Yamamoto, T, Matsuura, M, Fujii, T, Shinzaki, S, Mikami, Y, Arai, S, Oshima, J, Endo, Y, Yuasa, H, Hoshi, M, Sato, K, Hisamatsu, T

Get full text

P612 Long-term outcomes of treatment intervention according to the severity of small bowel capsule endoscopy findings in patients with Crohn’s disease: A Japanese single-centre coh... by Nasuno, M, Tanaka, H, Sugiyama, K, Miyakawa, M, Motoya, S

Get full text

P438 Efficacy and safety of ustekinumab for Ulcerative Colitis through 4 years in Asian patients: Final results from the sub-population of UNIFI long-term extension by Hisamatsu, T, Kim, H J, Motoya, S, Suzuki, Y, Ohnishi, Y, Marano, C, Imai, Y, Saadoun, C, Zhuo, J, Kawamura, S

Get full text

P415 Dose escalation of adalimumab and related prognostic factors in patients with Crohn's disease treated with adalimumab maintenance therapy: A single-centre, five-year cohort st... by Nasuno, M, Tanaka, H, Sugiyama, K, Miyakawa, M, Motoya, S

Get full text

P1189 Clinical features and surgical necessity rate of fistulising perianal disease in newly diagnosed patients with Crohn's disease: Interim analysis of inception cohort registry... by Takatsu, N, Yamamoto, T, Nakase, H, Shinzaki, S, Watanabe, K, Fujii, T, Okamoto, R, Matsuoka, K, Yamada, A, Kunisaki, R, Matsuura, M, Shiga, H, Bamba, S, Mikami, Y, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Maemoto, A, Yoshigoe, S, Tsuchiya, H, Nishimura, R, Murata, Y, Hisamatsu, T

Get full text

OP39 Shorter disease duration is associated with better outcomes in patients with moderately to severely active Crohn’s Disease treated with risankizumab: Results from the phase 3... by Peyrin-Biroulet, L, Colombel, J F, Louis, E, Ferrante, M, Motoya, S, Panaccione, R, Torres, J, Ungaro, R C, Kligys, K, Kalabic, J, Zambrano, J, Zhang, Y, D’Haens, G R

Get full text

P775 Disease activity and treatment patterns of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of inception cohort registry study of patients with C... by Shinzaki, S, Matsuoka, K, Fujii, T, Okamoto, R, Yamada, A, Kunisaki, R, Matsuura, M, Watanabe, K, Shiga, H, Takatsu, N, Bamba, S, Mikami, Y, Yamamoto, T, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Nakase, H, Maemoto, A, Murata, Y, Yoshigoe, S, Tsuchiya, H, Hisamatsu, T

Get full text

P564 Low-dose azathioprine improves long-term efficacy of infliximab maintenance treatment in Japanese patients with Crohn's disease by Nasuno, M., Motoya, S., Sugiyama, K., Miyakawa, M., Tanaka, H., Iida, T., Onodera, K., Nakase, H.

Get full text

P172 Clinical characteristics of newly diagnosed adult patients with Crohn’s disease in Japan: Interim analysis of Inception cohort registry study of patients with Crohn’s disease... by Matsuoka, K, Fujii, T, Okamoto, R, Yamada, A, Kunisaki, R, Matsuura, M, Watanabe, K, Shiga, H, Takatsu, N, Bamba, S, Mikami, Y, Yamamoto, T, Shimoyama, T, Motoya, S, Torisu, T, Kobayashi, T, Ohmiya, N, Saruta, M, Matsuda, K, Matsumoto, T, Nakase, H, Maemoto, A, Shinzaki, S, Murata, Y, Yoshigoe, S, Sasaki, A, Yajima, T, Hisamatsu, T

Get full text

Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016 by Masamune, Atsushi, Kikuta, Kazuhiro, Hamada, Shin, Tsuji, Ichiro, Takeyama, Yoshifumi, Shimosegawa, Tooru, Okazaki, Kazuichi

Get full text

DOP39 The first prospective, multicentre, randomised controlled trial on discontinuation of infliximab in ulcerative colitis in remission; endoscopic normalisation does not guarant... by Kobayashi, T, Motoya, S, Nakamura, S, Yamamoto, T, Nagahori, M, Tanaka, S, Hisamatsu, T, Hirai, F, Nakase, H, Watanabe, K, Matsumoto, T, Tanaka, M, Abe, T, Suzuki, Y, Watanabe, M, Hibi, T

Get full text

P323 The effectiveness of adalimumab maintenance treatment for Crohn's disease and related prognostic factors: a Japanese single-center study by Tanaka, H., Miyakawa, M., Nasuno, M., Motoya, S., Imamura, A.

Get full text

Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study by Fukuda, Yoshihiro, Matsui, Toshiyuki, Suzuki, Yasuo, Kanke, Kazunari, Matsumoto, Takayuki, Takazoe, Masakazu, Motoya, Satoshi, Honma, Terasu, Sawada, Koji, Yao, Tsuneyoshi, Shimoyama, Takashi, Hibi, Toshifumi

Get full text

HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma by Nakamura, Toru, Hayashi, Tsuyoshi, Kimura, Yasutoshi, Kawakami, Hiroshi, Takahashi, Kuniyuki, Ishiwatari, Hirotoshi, Goto, Takuma, Motoya, Masayo, Yamakita, Keisuke, Sakuhara, Yusuke, Ono, Michihiro, Tanaka, Eiichi, Omi, Makoto, Murakawa, Katsuhiko, Iida, Tomoya, Sakurai, Tamaki, Haba, Shin, Abiko, Takehiro, Ito, Yoichi M., Maguchi, Hiroyuki, Hirano, Satoshi

Get full text

P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study by Ungaro, R, Jordan, R, Yzet, C, Bossuyt, P, Baert, F, Vanasek, T, D’Haens, G R, Wilhelmus Joustra, V, Panaccione, R, Novacek, G, Reinisch, W, Armuzzi, A, Golovchenko, O, Prymak, O, Goldis, A, Travis, S, Hébuterne, X, Ferrante, M, Rogler, G, Fumery, M, Danese, S, Rydzewska, G, Pariente, B, Hertervig, E, Stanciu, C, Serrero, M, Diculescu, M, Peyrin-Biroulet, L, Laharie, D, Wright, J P, Gomollón, F, Irina, G, Schreiber, S, Motoya, S, Hellström, P M, Halfvarson, J, Colombel, J F

Get full text

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021 by Nakase, Hiroshi, Esaki, Motohiro, Hirai, Fumihito, Kobayashi, Taku, Matsuoka, Katsuyoshi, Matsuura, Minoru, Naganuma, Makoto, Saruta, Masayuki, Tsuchiya, Kiichiro, Uchino, Motoi, Watanabe, Kenji, Hisamatsu, Tadakazu

Get full text

P249 Usefulness of abdominal ultrasonography for patency assessment using the patency capsule by Ishii, M., Nasuno, M., Tanaka, H., Motoya, S., Miyakawa, M., Sugiyama, K., Honda, K., Matsumoto, H., Fujita, M., Manabe, N., Hata, J., Shiotani, A.

Get full text

P541 Clinical factors associated with discontinuation of combo or monotherapy for Crohn’s disease: A sub-analysis of a prospective randomised clinical trial (DIAMOND study) by Hisamatsu, T, Matsumoto, T, Watanabe, K, Nakase, H, Motoya, S, Yoshimura, N, Ishida, T, Kato, S, Nakagawa, T, Esaki, M, Nagahori, M, Matsui, T, Naito, Y, Kanai, T, Suzuki, Y, Nojima, M, Watanabe, M, Hibi, T

Get full text